Functional Properties of Human Embryonic Stem Cell-Derived Cardiomyocytes

被引:11
|
作者
Zeevi-Levin, Naama [2 ]
Itskovitz-Eldor, Joseph [2 ,4 ]
Binah, Ofer [1 ,2 ,3 ]
机构
[1] Technion Israel Inst Technol, Dept Physiol, Ruth & Bruce Rappaport Fac Med, IL-31096 Haifa, Israel
[2] Technion Israel Inst Technol, Sohnis Family Stem Cells Ctr, IL-31096 Haifa, Israel
[3] Technion Israel Inst Technol, Rappaport Family Inst Res Med Sci, IL-31096 Haifa, Israel
[4] Rambam Med Ctr, Haifa, Israel
来源
关键词
human embryonic stem cell-derived cardiomyocytes; cell-replacement therapy; functional properties; SKELETAL MYOBLAST TRANSPLANTATION; ACUTE MYOCARDIAL-INFARCTION; BONE-MARROW-CELLS; PROGENITOR CELLS; RAT HEARTS; SARCOPLASMIC-RETICULUM; CARDIAC REPAIR; IN-VITRO; DIFFERENTIATION; REGENERATION;
D O I
10.1615/CritRevEukarGeneExpr.v20.i1.40
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Cardiovascular diseases are the most frequent cause of death in the industrialized world, with the main contributor being myocardial infarction. Given the high morbidity and mortality rates associated with congestive heart failure, the shortage of donor hearts for transplantation, complications resulting from immunosuppression, and long-term failure of transplanted organs, regeneration of the diseased myocardium by cell transplantation is an attractive therapeutic modality. Because of their remarkable capacity for expansion and unquestioned cardiac potential, pluripotent human embryonic stem cells (hESC) represent an attractive candidate cell source for obtaining cardiomyocytes. Moreover, a number of recent reports have shown that hESC-derived cardiomyocytes (hESC-CM) survive after transplantation into infarcted rodent hearts, form stable cardiac implants, and result in preserved contractile function. Although the latter successes give good reason for optimism, considerable challenges remain in the successful application of hESC-CM to cardiac repair. Because it is desired that the transplanted cells fully integrate within the diseased myocardium, contribute to its contractile performance, and respond appropriately to various physiological stimuli, it is of crucial importance to be familiar with their functional properties. Therefore, this review describes the characteristics of hESC-CM, including their transcriptional profile, structural and electrophysiological properties, ion channel expression, excitation-contraction coupling, and neurohumoral responsiveness.
引用
收藏
页码:51 / 59
页数:9
相关论文
共 50 条
  • [1] Functional properties of human embryonic stem cell-derived cardiomyocytes
    Dolnikov, K
    Shilkrut, M
    Zeevi-Levin, N
    Danon, A
    Gerecht-Nir, S
    Itskovitz-Eldor, J
    Binah, O
    [J]. COMMUNICATIVE CARDIAC CELL, 2005, 1047 : 66 - 75
  • [2] Transcriptional and Functional Profiling of Human Embryonic Stem Cell-Derived Cardiomyocytes
    Cao, Feng
    Wagner, Roger A.
    Wilson, Kitchener D.
    Xie, Xiaoyan
    Fu, Ji-Dong
    Drukker, Micha
    Lee, Andrew
    Li, Ronald A.
    Gambhir, Sanjiv S.
    Weissman, Irving L.
    Robbins, Robert C.
    Wu, Joseph C.
    [J]. PLOS ONE, 2008, 3 (10):
  • [3] Molecular and pharmacological properties of human embryonic stem cell-derived cardiomyocytes
    Norstrom, Anders
    Akesson, Karolina
    Hardarson, Thorir
    Hamberger, Lars
    Bjorquist, Petter
    Sartipy, Peter
    [J]. EXPERIMENTAL BIOLOGY AND MEDICINE, 2006, 231 (11) : 1753 - 1762
  • [4] The electrocardiogram of human embryonic stem cell-derived cardiomyocytes
    Reppel, M
    Pillekamp, F
    Brockmeier, K
    Matzkies, M
    Bekcioglu, A
    Lipke, T
    Nguemo, F
    Bonnemeier, H
    Hescheler, J
    [J]. JOURNAL OF ELECTROCARDIOLOGY, 2005, 38 (04) : 166 - 170
  • [5] Functional role of thrombin on embryonic stem cell-derived cardiomyocytes
    Fleckenstein, D.
    Grandoch, M.
    Schroer, K.
    Doss, X.
    Sachinidis, A.
    Hescheler, J.
    Weber, A. -A
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2008, 377 : 57 - 57
  • [6] Assessment of the ultrastructural and proliferative properties of human embryonic stem cell-derived cardiomyocytes
    Snir, M
    Kehat, I
    Gepstein, A
    Coleman, R
    Itskovitz-Eldor, J
    Livne, E
    Gepstein, L
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2003, 285 (06): : H2355 - H2363
  • [7] Assessment of the ultrastructural and proliferative properties of human embryonic stem cell-derived cardiomyocytes
    Kehat, I
    Snir, M
    Gepstein, A
    Gepstein, L
    [J]. CIRCULATION, 2003, 108 (17) : 244 - 244
  • [8] Responses to endothelin in human embryonic stem cell-derived cardiomyocytes
    Wright, Jamie
    Ahmet, Selda
    Harding, Sian E.
    Ali, Nadire N.
    [J]. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2007, 42 : S88 - S88
  • [9] Potential applications of human embryonic stem cell-derived cardiomyocytes
    Caspi, O
    Gepstein, L
    [J]. CARDIAC ENGINEERING: FROM GENES AND CELLS TO STRUCTURE AND FUNCTION, 2004, 1015 : 285 - 298
  • [10] Differentiation pathways in human embryonic stem cell-derived cardiomyocytes
    Lev, S
    Kehat, I
    Gepstein, L
    [J]. COMMUNICATIVE CARDIAC CELL, 2005, 1047 : 50 - 65